Key result
Increasing systemic triglyceride-rich lipoprotein concentrations via IV chylomicrons stimulated a significant increase in lymphatic lipid and drug transport in rats.
Why the study?
Does an increase in systemic triglyceride-rich lipoproteins stimulate intestinal lymphatic lipid and drug transport in a rat model?
Does an increase in systemic triglyceride-rich lipoproteins stimulate intestinal lymphatic lipid and drug transport in a rat model?
Acute hypertriglyceridemia stimulates intestinal lipid absorption and lymphatic transport via a positive feedback mechanism, which may alter the absorption and reproducibility of highly lipophilic drugs.
Answers are grounded in this paper and cite their sources.
May alter lipophilic drug absorption reproducibility; leaves open translation of this feedback mechanism to humans.
Elevated systemic levels of triglyceride-rich lipoproteins (TRL) are a risk factor for the development of atherosclerosis. In patients with metabolic syndrome (MetS), intestinal TRL overproduction contributes to high systemic TRL levels, and recent studies suggest that systemic changes in MetS such as increases in plasma fatty acids and insulin resistance stimulate intestinal TRL production. The current study has examined whether increases in systemic TRL influence intestinal lipid transport and lipoprotein assembly pathways and evaluates the impact of these changes on the absorption and lymphatic transport of lipids and a model lipophilic drug (halofantrine). Mesenteric lymph-duct or bile-duct cannulated rats were administered IV saline or (14)C-labeled chylomicron (CM) (to increase systemic TRL) and intraduodenal (3)H lipids and drug. Changes to biliary lipid output and lymphatic lipid and drug transport were subsequently examined. Increasing systemic TRL concentrations stimulated a significant increase in lymphatic lipid and drug transport. The increased lipids in lymph were not derived from bile or the intestinal blood supply (fatty acid or IV infused (14)C-CM). Rather, an increase in lymphatic transport of duodenally sourced lipids was evident. Increasing plasma levels of TRL therefore stimulated lipid absorption and lymphatic transport via a positive feedback process. The data also suggest that the changes to intestinal TRL formation that result from raised systemic TRL levels may impact on the absorption of highly lipophilic drugs and therefore the reproducibility of drug treatments.
No takes yet. Share an insight, caveat, or question.
Trevaskis et al. (2011) studied Acute Hypertriglyceridemia. IV 14C-labeled chylomicron vs. IV saline was evaluated on Lymphatic lipid and drug transport. Increasing systemic triglyceride-rich lipoprotein concentrations via IV chylomicrons stimulated a significant increase in lymphatic lipid and drug transport in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: